is contrave a glp 1 drug Obesity Doctor: Add to GLP-1? Do This FIRST (FAQ) Pharmacology: Weight Loss Medications, Mechanisms

Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment

26% with placebo, Tables 2 and 3)

15: e48303

Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes

In addition, it was observed that those who took less than 80% of their prescribed statin therapy versus patients who completed their therapy had a 45% increase in all-cause mortality and a 15% increase in CVD events, suggesting that completion of therapy is crucial [79]

Systematic Reviews and Meta-analyses One collaborative meta-analysis that synthesized the cardiovascular outcomes reported the results from four studies and 45,568 patients on the add-on therapy modalities [20]